Drägerwerk AG & Co. KGaA (DRW3) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Headlines Articles Press releases Drägerwerk AG & Co. KGaA

Home
Companies
Drägerwerk AG & Co. KGaA

BRIEF

published on 05/08/2024 at 16:50, 6 months 12 days ago

Drägerwerk AG & Co. KGaA Enhances Focus on Sustainability and Quality with New Executive Board Role

Sustainability Executive Board Corporate Leadership Drägerwerk AG & Co. KGaA Quality Management
PRESS RELEASE

published on 05/08/2024 at 16:45, 6 months 12 days ago

Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility
Drägerwerk AG & Co. KGaA appoints Stefanie Hirsch as Chief Sustainability and Quality Officer to the Executive Board, emphasizing the importance of sustainability and quality

Sustainability Executive Board Quality Drägerwerk AG & Co. KGaA Stefanie Hirsch
BRIEF

published on 05/08/2024 at 15:38, 6 months 12 days ago

Drägerwerk AG & Co. KGaA Announces Substantial Dividend Hike at 2024 Shareholders' Meeting

Profitability Dividend Increase Annual Meeting Drägerwerk Corporate Objectives
PRESS RELEASE

published on 05/08/2024 at 15:33, 6 months 12 days ago

Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves significant dividend increase
Drägerwerk AG & Co. KGaA annual shareholders’ meeting approves significant dividend increase for fiscal year 2023. Company focuses on profitability, innovation leadership, and corporate objectives

Financial Report Dividend Increase Shareholders' Meeting Drägerwerk AG & Co. KGaA Corporate Objectives
BRIEF

published on 04/25/2024 at 07:35, 6 months 26 days ago

Dräger Reports Modest First Quarter Results for 2024

Earnings Forecast Market Performance Drägerwerk AG & Co. KGaA Q1 2024 Financial Results Safety And Medical Divisions
PRESS RELEASE

published on 04/25/2024 at 07:30, 6 months 26 days ago

Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024
Drägerwerk AG & Co. KGaA reports solid business performance in Q1 2024 with order intake slightly above prior year, net sales and earnings below due to base effects. Annual forecast confirmed

Order Intake Business Performance Q1 2024 Drägerwerk AG & Co. KGaA Annual Forecast
BRIEF

published on 04/15/2024 at 19:19, 7 months 5 days ago

Drägerwerk AG & Co. KGaA Reports Q1 2024 Preliminary Results: Earnings Dip, Forecast Intact

Earnings Report Drägerwerk AG & Co. KGaA Q1 2024 Financial Results Annual Forecast Medical And Safety Divisions
PRESS RELEASE

published on 04/15/2024 at 19:14, 7 months 5 days ago

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed
Drägerwerk AG & Co. KGaA reports preliminary figures for Q1 2024, with net sales and earnings below the strong prior-year quarter. Annual forecast confirmed

Net Sales Preliminary Results Earnings Q1 2024 Drägerwerk AG & Co. KGaA
BRIEF

published on 03/07/2024 at 07:35, 8 months 14 days ago

Drägerwerk AG & Co. KGaA Announces Significant Growth in Fiscal Year 2023

Dividend Increase Annual Report Fiscal Year 2023 Financial Growth Drägerwerk
PRESS RELEASE

published on 03/07/2024 at 07:30, 8 months 14 days ago

Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
Drägerwerk AG & Co. KGaA significantly increases net sales by 13% and profit, pays higher dividend. EBIT at EUR 166 million. Forecasting 1-5% increase in net sales for 2024

Net Sales Dividend Forecast Profit Drägerwerk AG & Co. KGaA

Accesswire

Published on 11/21/2024 at 13:00, 38 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 38 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 38 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 23 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 3 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 23 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 31 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 38 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 40 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 18 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE